Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Negative Prebiopsy Magnetic Resonance Imaging and Risk of Significant Prostate Cancer: Baseline and Long-Term Followup Results.

The Journal of urology - 1 Mar 2021

Buisset Julie, Norris Joseph M, Puech Philippe, Leroy Xavier, Ramdane Nassima, Drumez Elodie, Villers Arnauld, Olivier Jonathan

Abstract excerpt

PURPOSE: Prostate biopsy should be discussed with the patient in cases of negative magnetic resonance imaging and low clinical suspicion of prostate cancer.Our primary objective was to describe the risk of clinically significant prostate cancer in a negative magnetic resonance imaging biopsy naïve population at baseline and during long-term followup. The secondary objective was to evaluate clinical factors and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Magnetic Resonance Imaging

Share to Neoplasm Grading

Share to Neoplasm Staging

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 33080153
DOI: 10.1097/JU.0000000000001414

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Negative Prebiopsy Magnetic Resonance Imaging and Risk of Significant Prostate Cancer: Baseline and Long-Term Followup Results.PMID 33080153Read ↗

Impact of a new diagnostic pathway for prostate cancer - From systematic transrectal to targeted MRI fusion transperineal biopsiesSemantic proximity Read ↗

Reliability of Prostate Imaging Reporting and Data System Version 2.1 for Excluding Clinically Significant Prostate Cancer Using a 1.5 Tesla ScannerSemantic proximity Read ↗

MRI-Targeted Prostate Biopsy Introduces Grade Inflation and OvertreatmentSemantic proximity Read ↗

Optimizing Detection of Clinically Significant Prostate Cancer through Nomograms incorporating MRI, Clinical Features, and Advanced Serum BiomarkersSemantic proximity Read ↗

Screening for prostate cancer using PSA with and without MRI: systematic reviews with meta-analysisSemantic proximity Read ↗

False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS.Semantic proximity Read ↗

Temporal changes in the clinical approach to diagnosing prostate cancer.Semantic proximity Read ↗

Risk stratification in men with a negative prostate biopsy: an interim analysis of a prospective cohort study.Semantic proximity Read ↗

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging.Semantic proximity Read ↗

Prostate Cancer in Primary Care.Semantic proximity Read ↗

Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study.Semantic proximity Read ↗

Multiparametric Magnetic Resonance Imaging Histology for Assessing Tumor Interstitial Ratio in Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.